Bovine Mastitis Market Size

  • Report ID: 4647
  • Published Date: Jul 30, 2024
  • Report Format: PDF, PPT

Bovine Mastitis Market Size

Bovine Mastitis Market size was over USD 2.15 Billion in 2023 and is anticipated to cross USD 5.43 Billion by the end of 2036, growing at more than 7.4% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of bovine mastitis is estimated at USD 2.29 Billion. The growth of the market can be attributed to the worldwide rapid growing prevalence of bovine mastitis in cattle. For instance, as of now around 32% of Saharan countries have occurrences of Bovine Mastitis (BM). Mastitis is however common in Asian countries as well, with a prevalence of more than 54%. Further, the growing prevalence of bovine mastitis infections during the dry season, along with the improved benefits of non-antibiotic intramammary products such as Teat Sealants in deterring intramammary infections during the dry season, are predicted to drive the market expansion.

In addition to these factors that are believed to fuel the market growth of bovine mastitis include the surge in research and development activities for developing advanced treatment to treat bovine mastitis more effectively, followed by the poor hygiene rate in cattle, injury to the mammary section, as well as expanding awareness in the dairy farmers about the treatment of Bovine Mastitis (BM) in their cattle. Bovine Mastitis has emerged as a major concern in the dairy industry around the world, and dairy farmers have been facing significant financial losses as the incidence of this disease in cattle increases year after year. The significantly increasing burden of mastitis throughout the world is fueling up demand for the bovine mastitis market. For instance, until the first quarter of 2022, the most expensive charges associated with mastitis in Germany were milk wastage (varying from 28 to 51%, with an average rate of 36%) and rejected milk (varying from 12 to 32%, with an average price of 21%). Moreover, the prevalence of subclinical mastitis was estimated to cost approximately USD 810,000 per year in Colombian cattle farms, with milk production losses ranging from 1.5 to 12.8% per farm.


Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4647
  • Published Date: Jul 30, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of bovine mastitis is estimated at USD 2.29 Billion.

The bovine mastitis market size was over USD 2.15 Billion in 2023 and is anticipated to cross USD 5.43 Billion by the end of 2036, growing at more than 7.4% CAGR during the forecast period i.e., between 2024-2036. Enormous surge in dairy production across the globe, worldwide rise in the number of farm cattle, and globally escalating consumption of milk are some major factors driving the growth of the market.

North America is poised to hold largest industry share by 2036, attributed to massively increasing prevalence of bovine mastitis in cattle, and the significantly expanding dairy industry in the region.

Boehringer Ingelheim International GmbH, Zoetis Inc., Merck & Co., Inc., Ceva Santé Animale, Nimrod Veterinary Products Ltd, Bayer AG, ImmuCell Corporation, West Way Health, Neogen Corporation, Forte Healthcare Ltd.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample